AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis

Background: Progress has been made in genetic investigations on restenosis for the past 20 years, many studies regarding <i>AGTR1</i> rs5186 polymorphism and restenosis after percutaneous coronary intervention (PCI) have been published, but the result remains controversial. The study aim...

Full description

Bibliographic Details
Main Authors: Feng Lv, Yufeng Jiang, Yebao Wang, Ting Zhang, Yafeng Zhou
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/9/11/406
_version_ 1797465000638414848
author Feng Lv
Yufeng Jiang
Yebao Wang
Ting Zhang
Yafeng Zhou
author_facet Feng Lv
Yufeng Jiang
Yebao Wang
Ting Zhang
Yafeng Zhou
author_sort Feng Lv
collection DOAJ
description Background: Progress has been made in genetic investigations on restenosis for the past 20 years, many studies regarding <i>AGTR1</i> rs5186 polymorphism and restenosis after percutaneous coronary intervention (PCI) have been published, but the result remains controversial. The study aimed to explore the relationship between rs5186 polymorphism and the risk of restenosis after PCI. Methods: We performed a systematic search on PubMed, Web of Science, Embase, CNKI, and Wan Fang databases up to December 2021. Two authors individually extracted all useful data of each study involved in this meta-analysis and assessed the study quality using the Newcastle-Ottawa scale. Odds ratios (ORs) and 95% confidence intervals (CIs) were combined in different genetic models for evaluation using a random-effects model or fixed-effect model. Results: There were eventually 8 studies of 1111 cases and 4097 controls eligible for this meta-analysis. Significant associations were found between rs5186 polymorphism and restenosis after PCI.allelic (OR: 1.31, 95% CI: 1.17–1.47, <i>p</i> < 0.001), homozygous (OR: 1.90, 95% CI: 1.50–2.44, <i>p</i> < 0.001), heterozygous (OR: 1.10, 95% CI: 0.93–1.29, <i>p</i> = 0.27), recessive (OR: 1.80, 95% CI: 1.37–2.36, <i>p</i> < 0.001), dominant genetic model (OR: 1.24, 95% CI: 1.06–1.44, <i>p</i> = 0.006). Subgroup analyses indicated a significant association in Asians. Conclusions: The rs5186 polymorphism in the <i>AGTR1</i> gene increases the risk of restenosis after PCI in Asians significantly.
first_indexed 2024-03-09T18:15:14Z
format Article
id doaj.art-ef90f37de30542519ef71d93897bddfc
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-09T18:15:14Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-ef90f37de30542519ef71d93897bddfc2023-11-24T08:46:59ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-11-0191140610.3390/jcdd9110406AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-AnalysisFeng Lv0Yufeng Jiang1Yebao Wang2Ting Zhang3Yafeng Zhou4Department of Cardiology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou 215125, ChinaDepartment of Cardiology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou 215125, ChinaDepartment of Cardiology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou 215125, ChinaDepartment of Cardiology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou 215125, ChinaDepartment of Cardiology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou 215125, ChinaBackground: Progress has been made in genetic investigations on restenosis for the past 20 years, many studies regarding <i>AGTR1</i> rs5186 polymorphism and restenosis after percutaneous coronary intervention (PCI) have been published, but the result remains controversial. The study aimed to explore the relationship between rs5186 polymorphism and the risk of restenosis after PCI. Methods: We performed a systematic search on PubMed, Web of Science, Embase, CNKI, and Wan Fang databases up to December 2021. Two authors individually extracted all useful data of each study involved in this meta-analysis and assessed the study quality using the Newcastle-Ottawa scale. Odds ratios (ORs) and 95% confidence intervals (CIs) were combined in different genetic models for evaluation using a random-effects model or fixed-effect model. Results: There were eventually 8 studies of 1111 cases and 4097 controls eligible for this meta-analysis. Significant associations were found between rs5186 polymorphism and restenosis after PCI.allelic (OR: 1.31, 95% CI: 1.17–1.47, <i>p</i> < 0.001), homozygous (OR: 1.90, 95% CI: 1.50–2.44, <i>p</i> < 0.001), heterozygous (OR: 1.10, 95% CI: 0.93–1.29, <i>p</i> = 0.27), recessive (OR: 1.80, 95% CI: 1.37–2.36, <i>p</i> < 0.001), dominant genetic model (OR: 1.24, 95% CI: 1.06–1.44, <i>p</i> = 0.006). Subgroup analyses indicated a significant association in Asians. Conclusions: The rs5186 polymorphism in the <i>AGTR1</i> gene increases the risk of restenosis after PCI in Asians significantly.https://www.mdpi.com/2308-3425/9/11/406cardiovascular diseasers5186percutaneous coronary interventionpolymorphism
spellingShingle Feng Lv
Yufeng Jiang
Yebao Wang
Ting Zhang
Yafeng Zhou
AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
Journal of Cardiovascular Development and Disease
cardiovascular disease
rs5186
percutaneous coronary intervention
polymorphism
title AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
title_full AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
title_fullStr AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
title_full_unstemmed AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
title_short AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
title_sort agtr1rs5186 polymorphism is associated with the risk of restenosis after percutaneous coronary intervention a meta analysis
topic cardiovascular disease
rs5186
percutaneous coronary intervention
polymorphism
url https://www.mdpi.com/2308-3425/9/11/406
work_keys_str_mv AT fenglv agtr1rs5186polymorphismisassociatedwiththeriskofrestenosisafterpercutaneouscoronaryinterventionametaanalysis
AT yufengjiang agtr1rs5186polymorphismisassociatedwiththeriskofrestenosisafterpercutaneouscoronaryinterventionametaanalysis
AT yebaowang agtr1rs5186polymorphismisassociatedwiththeriskofrestenosisafterpercutaneouscoronaryinterventionametaanalysis
AT tingzhang agtr1rs5186polymorphismisassociatedwiththeriskofrestenosisafterpercutaneouscoronaryinterventionametaanalysis
AT yafengzhou agtr1rs5186polymorphismisassociatedwiththeriskofrestenosisafterpercutaneouscoronaryinterventionametaanalysis